ABMD

Abiomed Announces Several Reimbursement Milestones

[at noodls] – Four Commercial Insurers Institute Broad Impella Coverage Impella Economic Study Published in The Journal of Managed Care Medicine (JMCM) DANVERS, Mass., March 4, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboardSee who ABIOMED is hiring next, click here to view […]

Abiomed to Present at Cowen and Company 33rd Annual Health Care Conference

[at noodls] – DANVERS, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboardSee who ABIOMED is hiring next, click here to view […]

Abiomed Receives Close-Out Letter From Food and Drug Administration

[at noodls] – DANVERS, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that on February 19, 2013, Abiomed received … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboardSee who ABIOMED is hiring next, click here to view […]

Abiomed Announces Revenue of $38.3 Million, Up 19% and Record Impella Patient Usage, Up 26%

[at noodls] – DANVERS, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2013 revenue of $38.3 million, … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboardSee who ABIOMED is hiring next, click here to view […]

Abiomed Third Quarter Fiscal 2013 Earnings and Conference Call Notification

[at noodls] – DANVERS, Mass., Jan. 17, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD) announced today that on Wednesday, February 6, 2013, the Company will release financial results for the third quarter of fiscal … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboardSee who ABIOMED is hiring next, click here to […]

Abiomed to Present at Lazard Capital Markets 9th Annual Healthcare Conference

[at noodls] – DANVERS, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboard […]

Centers for Medicare and Medicaid Services Announces New Dedicated Category I CPT Physician Payment Rates for Impella

[at noodls] – Centers for Medicare and Medicaid Services Announces New Dedicated Category I CPT Physician Payment Rates for Impella DANVERS, Mass., Nov. 2, 2012 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboard […]

Abiomed to Present at 7th Annual Morningstar 2012 Management Behind the Moat Conference

[at noodls] – DANVERS, Mass., Oct. 30, 2012 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director, Investor … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboard […]

Abiomed Reschedules Its Second Quarter Fiscal 2013 Earnings Release and Conference Call Due to Hurricane Sandy

[at noodls] – Abiomed Reschedules Its Second Quarter Fiscal 2013 Earnings Release and Conference Call Due to Hurricane Sandy Company to Announce Second Quarter Financial Results on Thursday, November 1 DANVERS, Mass., … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboard […]

Abiomed Announces Clinical Progress on Symphony Program, Including Second Successful Implant in Canada

[at noodls] – Abiomed Announces Clinical Progress on Symphony Program, Including Second Successful Implant in Canada DANVERS, Mass., Oct. 23, 2012 (GLOBE NEWSWIRE) — Abiomed,Inc. (Nasdaq:ABMD), a leading provider of … moreView todays social media effects on ABMDView the latest stocks trending across Twitter. Click to view dashboard […]